These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34665940)

  • 21. An efficient CRISPR/Cas9 platform for targeted genome editing in rose (Rosa hybrida).
    Wang C; Li Y; Wang N; Yu Q; Li Y; Gao J; Zhou X; Ma N
    J Integr Plant Biol; 2023 Apr; 65(4):895-899. PubMed ID: 36460630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.
    Johansen AK; Molenaar B; Versteeg D; Leitoguinho AR; Demkes C; Spanjaard B; de Ruiter H; Akbari Moqadam F; Kooijman L; Zentilin L; Giacca M; van Rooij E
    Circ Res; 2017 Oct; 121(10):1168-1181. PubMed ID: 28851809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgene-free genome editing in marine algae by bacterial conjugation - comparison with biolistic CRISPR/Cas9 transformation.
    Sharma AK; Nymark M; Sparstad T; Bones AM; Winge P
    Sci Rep; 2018 Sep; 8(1):14401. PubMed ID: 30258061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial resistance to CRISPR-Cas antimicrobials.
    Uribe RV; Rathmer C; Jahn LJ; Ellabaan MMH; Li SS; Sommer MOA
    Sci Rep; 2021 Aug; 11(1):17267. PubMed ID: 34446818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A highly effective and self-transmissible CRISPR antimicrobial for elimination of target plasmids without antibiotic selection.
    Wongpayak P; Meesungnoen O; Saejang S; Subsoontorn P
    PeerJ; 2021; 9():e11996. PubMed ID: 34567840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand-displaying
    Li YG; Kishida K; Ogawa-Kishida N; Christie PJ
    mBio; 2023 Oct; 14(5):e0214323. PubMed ID: 37772866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re-engineering a mobile-CRISPR/Cas9 system for antimicrobial resistance gene curing and immunization in Escherichia coli.
    He YZ; Kuang X; Long TF; Li G; Ren H; He B; Yan JR; Liao XP; Liu YH; Chen L; Sun J
    J Antimicrob Chemother; 2021 Dec; 77(1):74-82. PubMed ID: 34613377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific gene repression by CRISPRi system transferred through bacterial conjugation.
    Ji W; Lee D; Wong E; Dadlani P; Dinh D; Huang V; Kearns K; Teng S; Chen S; Haliburton J; Heimberg G; Heineike B; Ramasubramanian A; Stevens T; Helmke KJ; Zepeda V; Qi LS; Lim WA
    ACS Synth Biol; 2014 Dec; 3(12):929-31. PubMed ID: 25409531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Expanded Plasmid-Based Genetic Toolbox Enables Cas9 Genome Editing and Stable Maintenance of Synthetic Pathways in Phaeodactylum tricornutum.
    Slattery SS; Diamond A; Wang H; Therrien JA; Lant JT; Jazey T; Lee K; Klassen Z; Desgagné-Penix I; Karas BJ; Edgell DR
    ACS Synth Biol; 2018 Feb; 7(2):328-338. PubMed ID: 29298053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome.
    Nath A; Bhattacharjee R; Nandi A; Sinha A; Kar S; Manoharan N; Mitra S; Mojumdar A; Panda PK; Patro S; Dutt A; Ahuja R; Verma SK; Suar M
    Biomed Pharmacother; 2022 Jul; 151():113122. PubMed ID: 35594718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR/Cas9-Mediated Re-Sensitization of Antibiotic-Resistant Escherichia coli Harboring Extended-Spectrum β-Lactamases.
    Kim JS; Cho DH; Park M; Chung WJ; Shin D; Ko KS; Kweon DH
    J Microbiol Biotechnol; 2016 Feb; 26(2):394-401. PubMed ID: 26502735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of CRISPR-Cas9 knock-in tools for free fatty acid production using the fast-growing cyanobacterial strain Synechococcus elongatus UTEX 2973.
    Racharaks R; Arnold W; Peccia J
    J Microbiol Methods; 2021 Oct; 189():106315. PubMed ID: 34454980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous CRISPR-Cas mediated in situ genome editing: State-of-the-art and the road ahead for engineering prokaryotes.
    Liu Z; Liu J; Yang Z; Zhu L; Zhu Z; Huang H; Jiang L
    Biotechnol Adv; 2023 Nov; 68():108241. PubMed ID: 37633620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9-Based Genome Editing Platform for
    Wang P; Yi Y; Lü X
    J Agric Food Chem; 2021 Dec; 69(50):15279-15289. PubMed ID: 34747603
    [No Abstract]   [Full Text] [Related]  

  • 35. CRISPR-Cas9 Toolkit for Genome Editing in an Autotrophic CO
    Li J; Zhang L; Xu Q; Zhang W; Li Z; Chen L; Dong X
    Microbiol Spectr; 2022 Aug; 10(4):e0116522. PubMed ID: 35766512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas Technologies and Applications in Food Bacteria.
    Stout E; Klaenhammer T; Barrangou R
    Annu Rev Food Sci Technol; 2017 Feb; 8():413-437. PubMed ID: 28245154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering Citrobacter freundii using CRISPR/Cas9 system.
    Alfaro T; Elmore JR; Stromberg ZR; Hutchison JR; Hess BM
    J Microbiol Methods; 2022 Sep; 200():106533. PubMed ID: 35779647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of an Efficient Genome Editing Tool in Bacillus licheniformis Using CRISPR-Cas9 Nickase.
    Li K; Cai D; Wang Z; He Z; Chen S
    Appl Environ Microbiol; 2018 Mar; 84(6):. PubMed ID: 29330178
    [No Abstract]   [Full Text] [Related]  

  • 39. Elimination of bla
    Tao S; Chen H; Li N; Fang Y; Zhang H; Xu Y; Chen L; Liang W
    BMC Microbiol; 2023 Oct; 23(1):310. PubMed ID: 37884864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA.
    Miller JB; Zhang S; Kos P; Xiong H; Zhou K; Perelman SS; Zhu H; Siegwart DJ
    Angew Chem Int Ed Engl; 2017 Jan; 56(4):1059-1063. PubMed ID: 27981708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.